The fourth and final day of #ASBMR15 started with some really interesting talks in the 'microenvironment and bone marrow niches' 'osteoclasts II' and the 'hormonal regulators' concurrent sessions - yes, annoyingly 3 good ones at the same time!! I was particulary interested in the role of plekhm1 in osteoclast lysosome secretion, how osteocytic JAK/STAT signalling … Continue reading Late breakers and Doughnut takers! #ASBMR15 day 4
A recent paper in the Lancet published yesterday has confirmed that a class of drugs called Bisphosphonates(BP) when given early to breast cancer patients can prevent breast cancer recurrence in the bone and improve breast cancer survival, but only in women who were postmenopausal when treatment began. HOPE for breastcancer patients then? YES and NO! Currently … Continue reading A drug costing less than 5p a day that can prevent 34,000 women a year dying from breast cancer sits on the shelf?